Results 171 to 180 of about 80,621 (304)

HTAPP_Test protocol_Dissociation of primary neuroblastoma core needle biopsy to a single-cell suspension for single-cell RNA-seq (using collagenase 4) v1

open access: gold, 2021
Isaac Wakiro   +6 more
openalex   +1 more source

Advancing Organ‐on‐Chip Models With a Sacrificial Granular Hydrogel Strategy for Enhanced Permeability and Biomimicry

open access: yesSmall Methods, EarlyView.
A reversed granular hydrogel strategy creates highly porous 3D matrices within bone marrow (BM)‐on‐chip devices. Sacrificial alginate microgels generate interconnected microporosity that enhances nano/microparticle and cell mobilitymimicking pathogen agents—from the perfused vascular channel into the BM compartment, while preventing cell sedimentation ...
Hugo R Caires   +10 more
wiley   +1 more source

Diagnostic Efficacy and Clinical Impact of Image-guided Core Needle Biopsy of Suspected Adult Nonvertebral Osteomyelitis. [PDF]

open access: yesOpen Forum Infect Dis
Winkler WL   +11 more
europepmc   +1 more source

Adult Soft Tissue Sarcoma Local Recurrence After Adjuvant Treatment Without Resection of Core Needle Biopsy Tract

open access: green, 2012
Odion Binitie   +5 more
openalex   +2 more sources

Recurrent Mastitis after Core Needle Biopsy: Case Report of an Unusual Complication after Core Needle Biopsy of a Phyllodes Tumor [PDF]

open access: bronze, 2012
Nikola Kasprowicz   +5 more
openalex   +1 more source

Flexible Cervical Photodynamic Therapy Device

open access: yesTranslational Biophotonics, EarlyView.
This paper aims to design a flexible photodynamic therapy device for the cervix and cervical vault, using an LED array, light guide, and flexible trumpet‐shaped homogenizer. Simulations and tests show output irradiance up to 98 mW/cm2 with < 14.2% variation, offering a low‐cost solution for cervical cancer and precancerous lesions.
Teng Jin   +5 more
wiley   +1 more source

Toward Precision Chemotherapy for Pancreatic Cancer Guided by Transcriptomic Signatures

open access: yesUnited European Gastroenterology Journal, EarlyView.
ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, with chemotherapy as the mainstay but highly variable efficacy and toxicity. Current regimens, such as FOLFIRINOX and gemcitabine‐based combinations, are selected empirically without validated biomarkers to guide choice.
Brice Chanez   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy